Arm-In-Arm With Heart Failure Experts: A Master Class in Optimizing Heart Failure Treatment With SGLT2 Inhibitors
Webinar/Online
Saturday, September 27, 2025 at 7:30am CT - 8:45am CT
Add this event to your calendar
Info
Topic
Despite overwhelming evidence for the cardiorenal protective effects of SGLT2 inhibitors and well-established guidelines supporting their use, this class of medications remains underused or delayed in eligible patients, even in patients with Class 1a recommendations. Recent studies have highlighted the economic and clinical value of early initiation of SGLT2 inhibitor therapy, particularly in the vulnerable period after hospitalization. Join us to hear experts discuss treatment of patients with heart failure and participate with them in small group case-study workshops.
Credits Offered
This event offers
1.25 contact hours
to attendees.
Accreditation Info:
ANCC.
Additional Information
Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Heart Failure.
Target Audience
This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with heart failure.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify key clinical gaps in heart failure management and emphasize the role of guideline-directed medical therapy in improving outcomes
- Assess the efficacy, safety, and cardiovascular benefits of early and sustained SGLT2 inhibitor use in heart failure treatment
- Develop and implement practical strategies to integrate SGLT2 inhibitors into personalized care plans for patients with heart failure across the spectrum on left ventricular ejection fraction
Agenda:
7:30 Welcome, Baseline Assessment
7:33 At the Heart of It: Latest Clinical Trial Data and Real-world Evidence Supporting SGLT2 Inhibitors in Heart Failure GDMT
7:53 “Every Encounter Is An Opportunity”: Optimizing GDMT in HF with SGLT2 Inhibitors
8:13 Navigating Choppy Waters: Optimizing Treatment and Patient Counseling Around Potential Side Effects
8:28 Post-assessment and Evaluation
8:30 Summarize Key Points and Question and Answer Session
8:45 Finish
Speakers
Clinical Professor
Duke University School of Nursing
Nurse Practitioner
Duke Heart Failure Access Clinic
Durham, North Carolina
President
Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
Department of Medicine
University of Mississippi Medical Center
Jackson, Mississippi
Medical Director
Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon
Associate Professor
Division of Cardiology
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina